Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.
暂无分享，去创建一个
J. Tabernero | A. Italiano | J. Soria | R. Dienstmann | J. Infante | B. Adamo | A. Mita | V. Moreno | V. Peddareddigari | E. Calvo | B. Zhong | F. Luo | J. Smit | M. Chatterjee‐Kishore | A. Gazzah | S. Platero | R. Bahleda | K. Stuyckens | J. Rodón | Suso J Platero